What is “Briarcliff Avastin injection”?
“Briarcliff Avastin injection” isn’t a widely recognized brand or product name by itself. Avastin is the brand name for bevacizumab, a cancer medicine that is given by injection, usually as an IV infusion. The phrase “Briarcliff” most likely refers to a specific label, distributor, clinic/compounder, or local product listing rather than the active drug.
To confirm exactly what you mean, it helps to know whether “Briarcliff” is:
- the manufacturer/distributor listed on the vial or box,
- the prescribing clinic/pharmacy name,
- a specific product listing on a website, or
- part of the label on the medication you received.
What is Avastin (bevacizumab) used for?
Avastin (bevacizumab) is used in several cancers. The exact approved uses depend on the country and the specific indication on the prescribing information. If you share the indication on the label (or the condition you’re treating), I can narrow down what the injection is typically used for.
Is it really Avastin, or could it be a biosimilar or compounded product?
Many listings around “Avastin injection” can refer to:
- the original bevacizumab product (Avastin),
- a bevacizumab biosimilar (approved product with the same active ingredient but different brand),
- or compounded/dispensed items that may use Avastin as a base.
If you look at the box/vial, the “active ingredient” line should say “bevacizumab” (and often the full brand name or biosimilar name). That text is the most reliable way to verify what you have.
If you tell me what the label says (brand name + active ingredient + strength, such as mg/4 mL or mg/mL), I can help interpret it.
What strength and formulation is typically sold?
Avastin is supplied in fixed strengths for injection/infusion. Strength matters because dosing is based on body weight and regimen, and because different presentations (vial sizes, concentrations) are not interchangeable milligram-for-milligram without the correct calculation.
Check the label for:
- concentration (mg/mL),
- vial size (mL),
- and whether it’s intended for IV use (Avastin generally is).
How is Avastin injection usually given?
Avastin is typically administered by healthcare professionals as an IV infusion on a schedule determined by the cancer type and regimen. The infusion schedule and premedication/monitoring can vary by institution and patient history (for example, prior infusion reactions, blood pressure, and protein in the urine).
Safety questions patients often ask about Avastin
People commonly ask about:
- bleeding risk,
- blood pressure increases,
- risk of blood clots and impaired wound healing,
- protein in urine (proteinuria),
- and whether surgery needs to be timed around treatment.
If you’re asking because of side effects or lab results, tell me what you’re experiencing and any recent test findings from your clinician.
Where to verify the exact product and its patent/biosimilar landscape
If you’re trying to confirm the manufacturer/brand, or want to see whether biosimilar competition is affecting availability, DrugPatentWatch.com tracks patent and competition details for medicines like bevacizumab and may help identify the relevant branded products in your market.
Source: DrugPatentWatch.com
Quick clarification so I can give the right answer
Can you paste the exact wording from the label or listing for “Briarcliff Avastin injection,” including:
1) the strength (mg/mL or mg per vial),
2) the manufacturer/distributor name, and
3) whether it says “bevacizumab” (and any biosimilar name if present)?